Clinical Trials Directory

Trials / Completed

CompletedNCT03462277

DNA Methylation and Hydroxymethylation Levels in Patients With Coronary Heart Disease

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Chongqing Medical University · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

The purpose of this trial is to investigate the relationship between DNA methylation and hydroxymethylation and the expression of DNMTs, TET family gene and the degree of coronary heart disease.

Detailed description

1. To determine the levels of DNA methylation and hydroxymethylation with coronary heart disease. 2. To investigate the relationship between DNA methylation and hydroxymethylation and the degree of coronary atherosclerosis.

Conditions

Timeline

Start date
2018-01-01
Primary completion
2018-08-01
Completion
2018-10-01
First posted
2018-03-12
Last updated
2019-07-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03462277. Inclusion in this directory is not an endorsement.

DNA Methylation and Hydroxymethylation Levels in Patients With Coronary Heart Disease (NCT03462277) · Clinical Trials Directory